نتائج البحث - Fatma Gossiel
- يعرض 1 - 11 نتائج من 11
-
1
-
2
-
3
-
4
-
5
-
6
Clinical utility of bone turnover markers in monitoring the withdrawal of treatment with oral bisphosphonates in postmenopausal osteoporosis حسب K.E. Naylor, Eugène McCloskey, Richard Jacques, Nicola Peel, Margaret Paggiosi, Fatma Gossiel, Jennifer Walsh, Richard Eastell
منشور في 2019Artigo -
7
Levels of serotonin, sclerostin, bone turnover markers as well as bone density and microarchitecture in patients with high-bone-mass phenotype due to a mutation in Lrp5 حسب Morten Frost, Tom Andersen, Fatma Gossiel, Stinus Hansen, Jens Bollerslev, Wim Van Hul, Richard Eastell, Moustapha Kassem, Kim Brixen
منشور في 2011Artigo -
8
Changes in bone mineral density at 3 years in postmenopausal women receiving anastrozole and risedronate in the IBIS-II bone substudy: an international, double-blind, randomised, p... حسب Ivana Šestak, Shalini Singh, Jack Cuzick, Glen M. Blake, Rajesh Patel, Fatma Gossiel, Rob Coleman, Mitch Dowsett, John Forbes, Anthony Howell, Richard Eastell
منشور في 2014Artigo -
9
Associations Between Serum Bone Biomarkers in Early Breast Cancer and Development of Bone Metastasis: Results From the AZURE (BIG01/04) Trial حسب Janet E. Brown, Emma Rathbone, Samantha Hinsley, Walter M. Gregory, Fatma Gossiel, Helen Marshall, Roger Burkinshaw, Helen Shulver, Hasina Thandar, Gianfilippo Bertelli, Keane Maccon, Angela Bowman, Andrew M. Hanby, Richard H. Bell, David Cameron, Robert E. Coleman
منشور في 2017Artigo -
10
Cortical-Bone Fragility — Insights from sFRP4 Deficiency in Pyle’s Disease حسب Pelin Özlem Şimşek‐Kiper, Hiroaki Saito, Francesca Gori, Sheila Unger, Eric Hesse, Kei Yamana, Riku Kiviranta, Nicolas Solban, Jeff Liu, Robert Brommage, Koray Boduroğlu, Luisa Bonafé, Belinda Campos‐Xavier, Esra Dikoglu, Richard Eastell, Fatma Gossiel, Keith Harshman, Gen Nishimura, Katta M. Girisha, Brian J. Stevenson, Hiroyuki Takita, Carlo Rivolta, Andrea Superti‐Furga, Roland Baron
منشور في 2016Artigo -
11
11β-HSD1 inhibition in men mitigates prednisolone-induced adverse effects in a proof-of-concept randomised double-blind placebo-controlled trial حسب Nantia Othonos, Riccardo Pofi, Anastasia Arvaniti, Sarah White, Ilaria Bonaventura, Nikolaos Nikolaou, Ahmad Moolla, Thomas Marjot, Roland H. Stimson, André P. van Beek, Martijn van Faassen, Andrea M. Isidori, Elizabeth Bateman, Ross Sadler, Fredrik Karpe, Paul M. Stewart, Craig Webster, Joanne Duffy, Richard Eastell, Fatma Gossiel, Thomas Cornfield, Leanne Hodson, Katherine J. Escott, Andrew K. Whittaker, Ufuk Kirik, Ruth L. Coleman, Charles A.B. Scott, Joanne Milton, Olorunsola F. Agbaje, Rury R. Holman, Jeremy Tomlinson
منشور في 2023Artigo
أدوات البحث:
موضوعات ذات صلة
Medicine
Internal medicine
Bone remodeling
Osteoporosis
Endocrinology
Biology
Bone mineral
Genetics
Pathology
Urology
Alkaline phosphatase
Alternative medicine
Biochemistry
Bisphosphonate
Breast cancer
Cancer
Cell biology
Double blind
Environmental health
Enzyme
Etidronic acid
Gastroenterology
Gene
N-terminal telopeptide
Osteocalcin
Placebo
Population
Postmenopausal osteoporosis
Sclerostin
Vitamin D and neurology